281 related articles for article (PubMed ID: 12686408)
1. The homozygote 10-copy genotype of variable number tandem repeat dopamine transporter gene may confer protection against Parkinson's disease for male, but not to female patients.
Lin JJ; Yueh KC; Chang DC; Chang CY; Yeh YH; Lin SZ
J Neurol Sci; 2003 May; 209(1-2):87-92. PubMed ID: 12686408
[TBL] [Abstract][Full Text] [Related]
2. [Association between genetic polymorphism of dopamine transporter gene and susceptibility to Parkinson's disease].
Wang J; Liu Z; Chen B
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):346-8. PubMed ID: 11798784
[TBL] [Abstract][Full Text] [Related]
3. [Association between dopamine transporter gene polymorphism and Parkinson's disease].
Zhang L; Shao M; Xu Q; Dong X; Yang J; Li Y; Chen B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):431-4. PubMed ID: 11774209
[TBL] [Abstract][Full Text] [Related]
4. Association of the dopamine transporter gene with Parkinson's disease in Korean patients.
Kim JW; Kim DH; Kim SH; Cha JK
J Korean Med Sci; 2000 Aug; 15(4):449-51. PubMed ID: 10983695
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease.
Kelada SN; Costa-Mallen P; Checkoway H; Carlson CS; Weller TS; Swanson PD; Franklin GM; Longstreth WT; Afsharinejad Z; Costa LG
Pharmacogenet Genomics; 2005 Sep; 15(9):659-68. PubMed ID: 16041244
[TBL] [Abstract][Full Text] [Related]
6. Association between genetic polymorphism of angiotensin-converting enzyme gene and Parkinson's disease.
Lin JJ; Yueh KC; Chang DC; Lin SZ
J Neurol Sci; 2002 Jul; 199(1-2):25-9. PubMed ID: 12084438
[TBL] [Abstract][Full Text] [Related]
7. Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson's disease: no association found.
Mercier G; Turpin JC; Lucotte G
J Neurol; 1999 Jan; 246(1):45-7. PubMed ID: 9987713
[TBL] [Abstract][Full Text] [Related]
8. Association study for Parkinson's disease and a dopamine transporter gene polymorphism (1215A/G).
Lin CN; Liu HC; Tsai SJ; Liu TY; Hong CJ
Eur Neurol; 2002; 48(4):207-9. PubMed ID: 12422069
[TBL] [Abstract][Full Text] [Related]
9. The homozygote AA genotype of the alpha1-antichymotrypsin gene may confer protection against early-onset Parkinson's disease in women.
Lin JJ; Yueh KC; Chang CY; Chen CH; Lin SZ
Parkinsonism Relat Disord; 2004 Dec; 10(8):469-73. PubMed ID: 15542006
[TBL] [Abstract][Full Text] [Related]
10. Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan.
Nishimura M; Kaji R; Ohta M; Mizuta I; Kuno S
Mov Disord; 2002 Jul; 17(4):831-2. PubMed ID: 12210886
[TBL] [Abstract][Full Text] [Related]
11. Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease.
Le Couteur DG; Leighton PW; McCann SJ; Pond Sm
Mov Disord; 1997 Sep; 12(5):760-3. PubMed ID: 9380062
[TBL] [Abstract][Full Text] [Related]
12. [Lack of association between VNTR polymorphism of DAT gene and schizophrenia].
Hauser J; Kapelski P; Czerski PM; Godlewski S; Dmitrzak-Weglarz M; Twardowska K; Rybakowski JK
Psychiatr Pol; 2002; 36(3):403-12. PubMed ID: 12149916
[TBL] [Abstract][Full Text] [Related]
13. The serotonin transporter gene and Parkinson's disease.
McCann SJ; McManus ME; Johnson AG; Mellick GD; Le Couteur DG; Pond SM
Eur Neurol; 2000; 44(2):108-11. PubMed ID: 10965163
[TBL] [Abstract][Full Text] [Related]
14. Genotypic association between dopamine transporter gene polymorphisms and schizophrenia.
Persico AM; Macciardi F
Am J Med Genet; 1997 Feb; 74(1):53-7. PubMed ID: 9034007
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease.
Higuchi S; Muramatsu T; Arai H; Hayashida M; Sasaki H; Trojanowski JQ
J Neural Transm Park Dis Dement Sect; 1995; 10(2-3):107-13. PubMed ID: 9620058
[TBL] [Abstract][Full Text] [Related]
16. The dopamine transporter gene and Parkinson's disease in a Chinese population.
Leighton PW; Le Couteur DG; Pang CC; McCann SJ; Chan D; Law LK; Kay R; Pond SM; Woo J
Neurology; 1997 Dec; 49(6):1577-9. PubMed ID: 9409349
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease.
Contin M; Martinelli P; Mochi M; Albani F; Riva R; Scaglione C; Dondi M; Fanti S; Pettinato C; Baruzzi A
Clin Neuropharmacol; 2004; 27(3):111-5. PubMed ID: 15190232
[TBL] [Abstract][Full Text] [Related]
18. DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease.
Purcaro C; Vanacore N; Moret F; Di Battista ME; Rubino A; Pierandrei S; Lucarelli M; Meco G; Fattapposta F; Pascale E
Neurosci Lett; 2019 Jan; 690():83-88. PubMed ID: 30316985
[TBL] [Abstract][Full Text] [Related]
19. Dopamine transporter genetic variants and pesticides in Parkinson's disease.
Ritz BR; Manthripragada AD; Costello S; Lincoln SJ; Farrer MJ; Cockburn M; Bronstein J
Environ Health Perspect; 2009 Jun; 117(6):964-9. PubMed ID: 19590691
[TBL] [Abstract][Full Text] [Related]
20. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression.
Fuke S; Suo S; Takahashi N; Koike H; Sasagawa N; Ishiura S
Pharmacogenomics J; 2001; 1(2):152-6. PubMed ID: 11911442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
